What is the Simple Disease Activity Index?

The Simple Disease Activity Index (SDAI) is a composite measure of inflammation and symptom burden in rheumatoid arthritis (RA). It combines a standardized joint examination, two global ratings on a 0–10 cm scale, and an acute-phase marker (C-reactive protein, CRP) into a single number that can be tracked over time and compared across visits. The index was developed to be straightforward to compute—literally a weighted-free sum of its parts—while aligning closely with physician judgment and other validated disease-activity tools.

SDAI is widely used in routine care and clinical trials, particularly within treat-to-target strategies that aim for sustained low disease activity or remission. Because each component is clinically interpretable on its own, the score stays transparent: when the total changes, clinicians can usually see whether joints, patient-reported severity, examiner impression, or CRP drove the shift.

Why measure disease activity with a composite index?

RA management depends on reducing inflammation to prevent joint damage and disability. No single finding captures the full picture: some patients have swollen joints with modest symptoms; others feel severely limited with minimal swelling. Acute-phase reactants can be discordant with exam findings in either direction. Composite indices integrate these dimensions so that treatment decisions reflect a balanced view of the disease rather than an isolated laboratory value or a single joint count.

Indices such as SDAI also improve communication with patients about goals (“moving toward remission” or “maintaining low disease activity”) and support consistent documentation when multiple providers share care.

Components of the SDAI

All five elements are measured at the same encounter when possible, using methods consistent with your clinic or trial protocol.

Tender joint count (TJC)

The tender joint count records how many of the assessed joints are painful on pressure or motion. The usual framework for SDAI is the 28-joint count (shoulders, elbows, wrists, metacarpophalangeal, proximal interphalangeal, and knee regions per standardized definitions). TJC ranges from 0 to 28. Accurate counting requires a consistent technique and the same joint list from visit to visit so that trends remain meaningful.

Swollen joint count (SJC)

The swollen joint count counts joints with clinically detectable synovitis (soft-tissue swelling attributable to inflammation within the joint). Like TJC, SJC is typically assessed over the same 28 joints, with values from 0 to 28. Training and calibration among examiners reduces variability, which otherwise can obscure true change in disease activity.

Patient global assessment (PGA)

The patient global assessment captures the patient’s overall perception of arthritis-related disease activity, usually anchored to a 0–10 cm visual analog scale (VAS), where 0 represents no activity and 10 the worst imaginable activity. Even when joint counts are low, a high PGA may reflect pain from non-inflammatory sources, fatigue, mood, or comorbidity—information that still matters for holistic care even if it complicates interpretation of inflammatory burden.

Evaluator global assessment (EGA)

The evaluator global assessment (often termed physician or assessor global) is the clinician’s 0–10 cm VAS rating of the patient’s current inflammatory disease activity based on history, examination, and available data at that visit. EGA correlates with joint counts and laboratory markers but can incorporate subtle findings that are difficult to quantify, provided the rater aims to rate inflammatory activity rather than overall disability alone.

C-reactive protein (CRP)

For SDAI, CRP must be expressed in mg/dL before it is added to the sum. Many laboratories report CRP in mg/L; dividing mg/L by 10 converts to mg/dL (for example, 8 mg/L = 0.8 mg/dL). CRP rises with systemic inflammation but can be influenced by infection, recent surgery, obesity, and other conditions. In a subset of RA patients, CRP may remain relatively low despite clinically active synovitis—an important reason to interpret SDAI in context rather than as an isolated rule.

How the score is calculated

The formula is an unweighted sum:

SDAI = TJC + SJC + PGA + EGA + CRP (mg/dL)

Practical notes:

• Joint counts are whole numbers; PGA, EGA, and CRP may be recorded with decimals depending on local practice.
• Because CRP enters linearly, large laboratory spikes can move the index noticeably even when joints appear stable—always consider alternative causes of CRP elevation.
• If CRP is unavailable or invalid, the related Clinical Disease Activity Index (CDAI) omits the laboratory term; SDAI and CDAI cutoffs are not interchangeable with DAS28 thresholds.

Interpreting the total: common disease-activity bands

The numerical total is interpreted with widely used thresholds that stratify patients from remission through high activity. These bands support treat-to-target discussions but do not, by themselves, mandate a specific therapy in every setting.

Some trial definitions of Boolean remission impose additional requirements beyond a single SDAI value (for example caps on tender or swollen joints and CRP). When applying those endpoints, follow the full published criteria rather than the summary score alone.

Using SDAI in clinical practice

In many centers, SDAI is collected at baseline and at follow-up visits alongside a management plan tied to explicit targets. Serial measurement helps distinguish true response from random variation, provided joint counts and CRP are collected under comparable conditions. Shared decision-making remains essential: a patient near a numeric remission threshold with unacceptable pain or toxicity may need an individualized plan that is not fully captured by the index.

Documentation of components—not only the total—supports auditing of quality metrics and helps the next clinician understand why the composite changed.

How SDAI compares with CDAI and DAS28

CDAI uses the same clinical globals and 28-joint counts but drops CRP. It is useful when a same-day CRP is missing, when acute-phase markers are known to be misleading, or when a lab-free score is preferred. Because CDAI lacks CRP, its numeric scale differs from SDAI’s; compare each index only to its own cutoffs.

DAS28 uses a different joint inventory and a nonlinear formula with either ESR or a transformed CRP term. DAS28 and SDAI values should not be treated as interchangeable; switching indices mid-course can make longitudinal comparison difficult unless you standardize the tool you plan to follow.

Limitations and pitfalls

• Examiner dependency: Joint counts vary with skill, time pressure, and inter-rater calibration.
• CRP confounding: Infection, trauma, and other inflammatory states can raise CRP independently of RA flare.
• Discordant low CRP: Active synovitis may exist with modest CRP, understating composite disease activity.
• PGA influence: Mood, fibromyalgia-like pain, sleep loss, and mechanical symptoms may raise PGA without reflecting synovitis—sometimes widening the gap between patient experience and inflammatory markers.
• Extra-articular and structural disease: SDAI emphasizes peripheral joint inflammation and globals; it does not fully encode lung, ocular, or advanced damage-related disability without complementary assessment.